2026 reviewUpdated 28 Jul 2026
Blueberry Funded Review 2026: Broker-Grade Execution, a Risk Team on Overdrive
4.1
607 trader reviews
Ratings aggregated from publicly posted trader reviews on independent review platforms, captured 28 Jul 2026. We analyse them — we don't collect them.
The contradiction at the heart of 607 reviews
On trading conditions, Blueberry Funded's reviews read like a broker's marketing deck — because the firm is backed by one (Blueberry, the Australian brokerage). Tight spreads on gold and indices, minimal slippage even in volatility, a fast-updating dashboard, responsive support: this praise is constant across the 404 five-star reviews, and even many negative reviewers concede it.
Then there are the 101 one-star reviews — 16.6%, essentially tied with FXIFY for the highest share we track. And unlike FXIFY's scattered failure modes, Blueberry's concentrate into a single mechanism with a visible date signature.
The spring 2026 wave
An unmistakable cluster of March–April 2026 reviews describes funded accounts and payouts terminated under discretionary conduct labels:
- ›"Chasing losses" — for opening an opposite-direction gold trade 21 seconds after closing a loser, with no size increase and no martingale, per the reviewer's own breakdown.
- ›"Toxic trading" and "violent trading" — labels several traders report receiving with no trade-level explanation, one right before payout day with MT5 access already cut.
- ›Clause 12.2(viii) — the catch-all that lets the company decide a strategy doesn't "represent individual trading in good faith", cited to a $50K trader at the 3% payout threshold.
- ›Hardware fingerprints: a $200K account up 3% terminated over a "unique iPhone hardware ID from Nigeria" the trader says he's never owned or visited; algo accusations against manual MT5 traders; martingale flags the firm itself walked back after long disputes — then re-flagged.
- ›Post-payout tightening: a 20–30-account customer hit with a 1% risk limiter immediately after his first payout, then terminated days before his second; another funded trader banned after two payouts when a "flag" review found issues it never specified; a first-day $7,114 profit denied outright.
The wave has cooled but not stopped — late-July reviews still include a denied payout with "unclear rule enforcement" and a credential-delivery complaint. Meanwhile the July flow also contains plenty of five-star support and spread praise, plus one four-star reviewer sensibly warning buyers to "understand their 1.5% rule perfectly" — the per-trade risk cap at the centre of several disputes.
How we read it
Two things look simultaneously true. First: Blueberry's execution stack is genuinely excellent for the price tier — for pure trade quality, reviewers rank it above every discount rival. Second: through spring 2026 its risk team ran the most aggressive discretionary-termination campaign in our dataset, using subjective labels that traders couldn't audit or appeal. A 16.6% one-star share at 607 reviews is not noise; it's a pricing signal. Treat the excellent conditions as compensation for elevated enforcement risk, not as a free lunch.
Ground rules if you buy anyway
- ›Respect the 1.5% per-trade risk cap with margin for slippage and commissions, and avoid rapid re-entries after losers — the "chasing losses" standard has been applied to a 21-second gap.
- ›Trade boring: consistent sizing, no bursts, no revenge sequences. The conduct labels punish *patterns*, and you won't get to argue the definition.
- ›Keep withdrawals small and frequent; multiple disputes ignited between the first and second payout.
- ›Single device, single location. The hardware-ID case shows the fingerprinting is aggressive and the appeal path shallow.
Live pricing and the current code are on the Blueberry Funded profile and promo page. If you want Blueberry-grade spreads with a calmer enforcement record, compare against E8 Markets — the trade-off runs exactly along that axis.
Blueberry Funded
Rules, prices and payout terms — verified against the firm's own published data.
This analysis reflects public reviews at the time of writing; individual experiences vary and review platforms include incentivised submissions. We may earn a commission when you use our links or codes, at no extra cost to you. Trading involves substantial risk of loss.